Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53) 53
life sciences & biomedicine (49) 49
science & technology (49) 49
female (43) 43
corticosteroid-induced osteoporosis (35) 35
osteoporosis (35) 35
male (31) 31
rheumatology (31) 31
middle aged (26) 26
osteoporosis - chemically induced (26) 26
biological and medical sciences (24) 24
bone density (24) 24
medical sciences (24) 24
aged (21) 21
pharmacology. drug treatments (20) 20
bone density - drug effects (19) 19
medicine general & introductory medical sciences (17) 17
osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] (17) 17
randomized controlled trials as topic (17) 17
adrenal cortex hormones - adverse effects (16) 16
adult (16) 16
bisphosphonates (15) 15
osteoporosis - drug therapy (14) 14
osteoporosis - prevention & control (14) 14
general & internal medicine (13) 13
medicine, general & internal (13) 13
bone density conservation agents - therapeutic use (12) 12
corticosteroid-induced-osteoporosis, prevention (12) 12
glucocorticoids - adverse effects (12) 12
bone mineral density (11) 11
drug toxicity and drugs side effects treatment (11) 11
pharmacological therapies (11) 11
treatment [pharmacological agents] (11) 11
endocrinology & metabolism (10) 10
medicine & public health (10) 10
adolescent (9) 9
bisphosphonates, therapeutic use (9) 9
bone density conservation agents (9) 9
bones, joints and connective tissue. antiinflammatory agents (9) 9
diphosphonates - therapeutic use (9) 9
spinal fractures (9) 9
diseases of the osteoarticular system (8) 8
osteoporosis, postmenopausal - drug therapy (8) 8
osteoporosis, postmenopausal - prevention & control (8) 8
prospective studies (8) 8
spinal fractures - prevention & control (8) 8
absorptiometry, photon (7) 7
aged, 80 and over (7) 7
calcitonin (7) 7
calcium (7) 7
child (7) 7
corticosteroid induced osteoporosis (7) 7
corticosteroid-induced-osteoporosis, treatment (7) 7
etidronic acid - therapeutic use (7) 7
fractures (7) 7
fractures, bone (7) 7
fractures, bone - prevention & control (7) 7
glucocorticoids (7) 7
osteoporosis, postmenopausal (7) 7
toxicity: osteoarticular system (7) 7
bisphosphonate (6) 6
bone density - physiology (6) 6
calcium, therapeutic use (6) 6
drug administration schedule (6) 6
etidronic-acid, therapeutic use (6) 6
menopause (6) 6
osteoporosis - complications (6) 6
osteoporosis - physiopathology (6) 6
osteoporosis. osteomalacia. paget disease (6) 6
prescribing (6) 6
prevention (6) 6
alendronate (5) 5
arthritis, rheumatoid - drug therapy (5) 5
bone density conservation agents - adverse effects (5) 5
bones (5) 5
corticosteroid induced osteoporosis, treatment (5) 5
corticosteroids (5) 5
corticosteroid‐induced osteoporosis (5) 5
double-blind method (5) 5
hormonal-replacements, therapeutic use (5) 5
internal medicine (5) 5
non‐pharmacological therapies (5) 5
pharmacology & pharmacy (5) 5
pharmacology/toxicology (5) 5
risedronate (5) 5
risk factors (5) 5
treatment [non‐pharmacological] (5) 5
treatment outcome (5) 5
vertebral fractures (5) 5
abridged index medicus (4) 4
alendronic-acid, therapeutic use (4) 4
calcitonin - therapeutic use (4) 4
calcitonin, therapeutic use (4) 4
complementary & alternative medicine (4) 4
complications and side effects (4) 4
drug therapy (4) 4
etidronate (4) 4
etidronic acid - administration & dosage (4) 4
follow-up studies (4) 4
glucocorticoids - therapeutic use (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Bisphosphonates for steroid‐induced osteoporosis
by Allen, Claire S and Yeung, James HS and Vandermeer, Ben and Homik, Joanne and Homik, Joanne
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, pp. CD001347 - CD001347
Osteoporosis | Glucocorticoids | Diphosphonates | Bone Density Conservation Agents | Spinal Fractures | Rheumatology | Osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] | Treatment [pharmacological agents] | Pharmacological therapies | Medicine General & Introductory Medical Sciences | Bisphosphonates | Randomized Controlled Trials as Topic | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Spinal Fractures - prevention & control | Osteoporosis - chemically induced | Osteoporosis - prevention & control | Humans | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Adult | Glucocorticoids - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease—A cross sectional study
by Jørgensen, N.R and Schwarz, P and Holme, I and Henriksen, B.M and Petersen, L.J and Backer, V
Respiratory medicine, ISSN 0954-6111, 2006, Volume 101, Issue 1, pp. 177 - 185
Pulmonary/Respiratory | Vertebral fractures | Pulmonary function | Secondary osteoporosis | Corticosteroid induced osteoporosis | COPD | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Osteoporosis. Osteomalacia. Paget disease | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Injuries of the limb. Injuries of the spine | Medical sciences | Traumas. Diseases due to physical agents | Chronic obstructive pulmonary disease, asthma | Pneumology | Spirometry | Bone Density | Prevalence | Cross-Sectional Studies | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Pulmonary Disease, Chronic Obstructive - complications | Bone Diseases, Metabolic - complications | Osteoporosis - complications | Fractures, Bone - complications | Fractures, Bone - physiopathology | Female | Aged | Bone Diseases, Metabolic - physiopathology | Osteoporosis - physiopathology | Osteoporosis | Medical research | Care and treatment | Lung diseases, Obstructive | Medicine, Experimental | Development and progression | Prevalence studies (Epidemiology) | Bones | Bone density | Disease | Older people | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Exercise for preventing and treating osteoporosis in postmenopausal women
by Howe, Tracey E and Shea, Beverley and Dawson, Lesley J and Downie, Fiona and Murray, Ann and Ross, Craig and Harbour, Robin T and Caldwell, Lynn M and Creed, Gisela and Howe, Tracey E
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 2011, Volume 2011, Issue 7, pp. CD000333 - CD000333
Bone Density | Rheumatology | Fractures, Bone | Non‐pharmacological therapies | Randomized Controlled Trials as Topic | Prevention | Osteoporosis | Exercise | Osteoporosis, Postmenopausal | Osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] | Treatment [non‐pharmacological] | Rehabilitation | Medicine General & Introductory Medical Sciences | Bone Density - physiology | Humans | Female | Exercise - physiology | Osteoporosis, Postmenopausal - therapy | Fractures, Bone - therapy | Osteoporosis, Postmenopausal - prevention & control | Fractures, Bone - prevention & control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Chinese herbal medicines for treating osteoporosis
by Liu, Yunxia and Liu, Jian Ping and Xia, Yun and Liu, Yunxia
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2014, Issue 3, pp. CD005467 - CD005467
Osteoporosis | Drugs, Chinese Herbal | Complementary & alternative medicine | Bone Density Conservation Agents | Rheumatology | Osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] | Treatment [non‐pharmacological] | Herbal | Non‐pharmacological therapies | Phytotherapy | Medicine General & Introductory Medical Sciences | Randomized Controlled Trials as Topic | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bone Density Conservation Agents - therapeutic use | Osteoporosis - drug therapy | Phytotherapy - methods | Drugs, Chinese Herbal - therapeutic use | Humans | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Bisphosphonate therapy for children and adolescents with secondary osteoporosis
by Ward, Leanne and Tricco, Andrea and Phuong, Phuc‐Nhi and Cranney, Ann and Barrowman, Nick and Gaboury, Isabelle and Rauch, Frank and Tugwell, Peter and Moher, David and Ward, Leanne
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2007, Volume 2010, Issue 7, pp. CD005324 - CD005324
Osteoporosis | Bone Density | Diphosphonates | Bone Density Conservation Agents | Child health | Rheumatology | Osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] | Treatment [pharmacological agents] | Controlled Clinical Trials as Topic | Pharmacological therapies | Medicine General & Introductory Medical Sciences | Bisphosphonates | Bone density conservation agents [adverse effects; therapeutic use] | Diphosphonates [adverse effects; therapeutic use] | Bone density [drug effects] | Controlled clinical trials as topic | Adolescent | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bone Density - drug effects | Bone Density Conservation Agents - adverse effects | Osteoporosis - prevention & control | Humans | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Osteoporosis - drug therapy | Child | Diphosphonates - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
by Saag, Kenneth G and Wagman, Rachel B and Geusens, Piet and Adachi, Jonathan D and Messina, Osvaldo D and Emkey, Ronald and Chapurlat, Roland and Wang, Andrea and Pannacciulli, Nicola and Lems, Willem F
The lancet. Diabetes & endocrinology, ISSN 2213-8587, 06/2018, Volume 6, Issue 6, pp. 445 - 454
UNITED-STATES | CONTROLLED-TRIAL | FRACTURE | MANAGEMENT | THERAPY | INHIBITION | PREVENTION | PREVALENCE | CORTICOSTEROID-INDUCED OSTEOPOROSIS | POSTMENOPAUSAL WOMEN | ALENDRONATE | INDUCED BONE LOSS | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Risedronic Acid - therapeutic use | Double-Blind Method | Osteoporosis - prevention & control | Humans | Middle Aged | Osteoporotic Fractures - prevention & control | Male | Denosumab - therapeutic use | Bone Density - drug effects | Risedronic Acid - pharmacology | Female | Aged | Denosumab - pharmacology | Glucocorticoids - adverse effects | Risedronate | Osteoporosis | Dosage and administration | Denosumab | Comparative analysis | Drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights